Nuplazid Lawsuit
Nuplazid (pimavanserin) is a relatively new drug approved to treat patients with Parkinson's disease who suffer delusions, psychosis symptoms and hallucinations. Since it was approved for the market, however, an astonishing number of patients have suffered serious adverse events—including death and life-threatening events—while other patients say they did not obtain the benefits they expected.